SCHEMBL22843448

SCHEMBL22843448

CN(CP)S(=O)(=O)c1ccc(NCc2ccc(OC(F)(F)F)cc2)c(-c2cn(C)cn2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.41
▸ YAP1 P46937 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ BRD4 O60885 1/20 0.38
▸ FLT1 P17948 3/20 0.37
▸ KDR P35968 3/20 0.37
▸ NTRK1 P04629 5/20 0.35
▸ KCNH2 Q12809 4/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP3 P08254 1/20 0.35
▸ MMP7 P09237 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP8 P22894 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ NTRK3 Q16288 1/20 0.35
▸ NTRK2 Q16620 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ VNN1 O95497 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22718282 0.90 VNN1 (0.41) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22718108 0.85 TEAD1 (0.57) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22843416 0.85 TEAD1 (0.45) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22843423 0.81 CA12 (0.41) ALDH1A1SMN1; SMN2MMP2MMP3MMP9
SCHEMBL24496259 0.79 TEAD1 (0.56) TEAD1YAP1ALDH1A1SMN1; SMN2FLT1
SCHEMBL29648453 0.79 TEAD1 (0.56) TEAD1YAP1ALDH1A1SMN1; SMN2FLT1
SCHEMBL29438890 0.77 TEAD1 (0.42) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22718241 0.76 TEAD1 (0.54) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22843397 0.76 TP53 (0.47) TEAD1YAP1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22843451 0.76 TEAD1 (0.54) TEAD1YAP1ALDH1A1SMN1; SMN2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760728-B2 Tead inhibitors and uses thereof Ikena Oncology, Inc. (US) 2023-09-19 — — US disclosed
US-11274082-B2 Tead inhibitors and uses thereof Ikena Oncology, Inc. (US) 2022-03-15 — — US disclosed
US-20200407327-A1 TEAD INHIBITORS AND USES THEREOF THE EHE FOUNDATION 2020-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274082-B2 Tead inhibitors and uses thereof TEAD2, TEAD3, TEAD4 TEAD1 4/4885YAP1 111/4885ALDH1A1 1195/4885
US-11760728-B2 Tead inhibitors and uses thereof TEAD2, TEAD3, TEAD4 TEAD1 4/4885YAP1 111/4885ALDH1A1 1195/4885
US-20200407327-A1 TEAD INHIBITORS AND USES THEREOF TEAD2, TEAD3, TEAD4 TEAD1 4/4885YAP1 111/4885ALDH1A1 1195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback